Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results for BRLI
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 26.09 - 36.75
Open     -
Vol / Avg. 0.00/152,229.00
Mkt cap 922.75M
P/E 18.35
Div/yield     -
EPS 1.81
Shares 27.78M
Beta 0.74
Inst. own 81%
Jul 10, 2015
Bio-Reference Laboratories Inc Annual Shareholders Meeting (Estimated) - 9:00AM EDT - Add to calendar
Jun 9, 2015
Bio-Reference Laboratories Inc at William Blair Annual Growth Stock Conference - 11:10AM EDT - Add to calendar
Jun 3, 2015
Q2 2015 Bio-Reference Laboratories Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 5, 2015
Q1 2015 Bio-Reference Laboratories Inc Earnings Call - Webcast
Mar 5, 2015
Q1 2015 Bio-Reference Laboratories Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2014
Net profit margin 3.18% 5.62%
Operating margin 5.71% 10.02%
EBITD margin - 13.05%
Return on average assets 5.50% 10.39%
Return on average equity 8.25% 15.84%
Employees 3,406 -
CDP Score - -


481 Edward H Ross Dr
ELMWOOD PARK, NJ 07407-3118
United States - Map
+1-201-7912186 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health and correctional health care. The Company has a network of approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in of New Jersey and Maryland as well as some parts of Pennsylvania, Delaware and Connecticut. In August 2013, the Company acquired most of the assets of Hunter Laboratories, located in the Bay area.

Officers and directors

Marc D. Grodman M.D. Chairman of the Board, President, Chief Executive Officer
Age: 63
Bio & Compensation  - Reuters
Nicholas Papazicos Chief Financial Officer
Age: 56
Bio & Compensation  - Reuters
Howard Dubinett Chief Operating Officer, Executive Vice President, Director
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Ilan Kaufthal Director
Age: 67
Bio & Compensation  - Reuters
Sam Singer Director
Age: 71
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Benincasa Independent Director
Age: 65
Bio & Compensation  - Reuters
Harry Elias Independent Director
Age: 84
Bio & Compensation  - Reuters
John Roglieri M.D. Independent Director
Age: 75
Bio & Compensation  - Reuters